Topic: flu vaccine

Seqirus expects to offer 50 million flu vaccine doses, while GSK plans to boost its supplies to 40 million to 45 million, its highest total ever.

Sanofi will increase the supplies of Flublok Quadrivalent and Fluzone High-Dose to 25 million doses for the coming flu season.

Seqirus' cell-based flu vaccine was 26.5% effective at keeping those 65 and older out of the hospital in the past flu season, an FDA study finds.

Sanofi raised the price of Flublok by 12.5% last year, its only increase above the U.S. National Health Expenditure growth rate.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Bill Gates and Larry Page set up a challenge to develop a universal flu shot.